TRIM31 is upregulated in a variety of tumors, such as hepatocellular carcinoma, gallbladder cancer and colorectal cancer, and is associated with an aggressive phenotype, advanced disease status and poor prognosis (15, 16, 20). Here, TRIM31 is linked to hepatocellular carcinoma.